article thumbnail

Things To Avoid With Degenerative Disc Disease

Oviedo Chiropractic

Here are some things to avoid with degenerative disc disease. However, for those living with degenerative disc disease, this process generally happens earlier—and causes more pain. If you’ve recently been diagnosed with disc degeneration, you’re probably wondering what to expect.

article thumbnail

Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain

OrthoSpineNews

NEW YORK, September 24, 2024 –(BUSINESS WIRE)– Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc Disease (DDD), today announced the completion of enrollment of its U.S. Phase 3 clinical trial of SB-01 For Injection (SB-01).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Year Same Spine

ChiroJunky

Same Spine Every December 31st as the year turns another age, your spine also grow older. Though some organs tissues have the ability to regenerate, like the liver, the spine ages and degenerates overtime. The spine is the weight-baring back one of the body. The spine has several functions that maintain us through life.

Spine 130
article thumbnail

Degenerative Disc Disease Treatment Market Is Expected To Reach Revenue Of USD 66.2 Bn By 2033, At 7.7% CAGR: Dimension Market Research

OrthoSpineNews

Advancements and Projections in the Global Degenerative Disc Disease Treatment Market: Insights, Trends, Opportunities, and Recent Developments New York, Oct. 08, 2024 (GLOBE NEWSWIRE) — Overview – The Global Degenerative Disc Disease Treatment Market is projected to reach USD 34.0

article thumbnail

DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease

OrthoSpineNews

Receives FDA acceptance on Phase III clinical protocols for parallel pivotal and confirmatory trials Achieves alignment with FDA on Chemistry, Manufacturing, and Controls (CMC) aspects of Phase III program SALT LAKE CITY, July 16, 2024 /PRNewswire/ — DiscGenics, Inc.,

article thumbnail

33 Medical Wins 2024 Best Technology in Spine Award for Innovative NuvoDisc® Device

OrthoSpineNews

a leader in cutting-edge spinal health innovations, is proud to announce that its NuvoDisc® medical device has been awarded the prestigious 2024 Best Technology in Spine Award. Boca Raton, FL, Sept. 27, 2024 (GLOBE NEWSWIRE) — 33 Medical, Inc.,

article thumbnail

Landmark Clinical Study Demonstrates Superiority of 3-Level Circumferential Cervical Fusion Over Anterior Cervical Fusion Alone

OrthoSpineNews

July 11, 2024 /PRNewswire/ — Providence Medical Technology announces FDA Clearance of its CORUS™ Posterior Cervical Stabilization System (PCSS) for the treatment of up to 3-level cervical Degenerative Disc Disease (DDD).